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Abstract
Background: Multi-tracer positron emission tomography (PET) imaging can be
accomplished by applying multi-tracer compartment modeling. Recently, a method
has been proposed in which the arterial input functions (AIFs) of the multi-tracer PET
scan are explicitly derived. For that purpose, a gamma spectroscopic analysis is
performed on blood samples manually withdrawn from the patient when at least
one of the co-injected tracers is based on a non-pure positron emitter. Alternatively,
these blood samples required for the spectroscopic analysis may be obtained and
analyzed on site by an automated detection device, thus minimizing analysis time
and radiation exposure of the operating personnel. In this work, a new automated
blood sample detector based on silicon photomultipliers (SiPMs) for single- and
multi-tracer PET imaging is presented, characterized, and tested in vitro and in vivo.
Results: The detector presented in this work stores and analyzes on-the-fly single
and coincidence detected events. A sensitivity of 22.6 cps/(kBq/mL) and 1.7 cps/
(kBq/mL) was obtained for single and coincidence events respectively. An energy
resolution of 35% full-width-half-maximum (FWHM) at 511 keV and a minimum
detectable activity of 0.30 ± 0.08 kBq/mL in single mode were obtained. The in vivo
AIFs obtained with the detector show an excellent Pearson’s correlation (r = 0.996,
p < 0.0001) with the ones obtained from well counter analysis of discrete blood
samples. Moreover, in vitro experiments demonstrate the capability of the detector
to apply the gamma spectroscopic analysis on a mixture of 68Ga and 18F and
separate the individual signal emitted from each one.
Conclusions: Characterization and in vivo evaluation under realistic experimental
conditions showed that the detector proposed in this work offers excellent sensibility
and stability. The device also showed to successfully separate individual signals
emitted from a mixture of radioisotopes. Therefore, the blood sample detector
presented in this study allows fully automatic AIFs measurements during single- and
multi-tracer PET studies.
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Background
Positron emission tomography (PET) is a diagnostic molecular imaging technique that
allows in vivo visualization of metabolic processes within the body based on the biodis-
tribution of a radiotracer that is administered to the patient. Many applications of this
technique are based on dynamic PET scans that provide access to the tracer kinetics
in vivo. Furthermore, in many clinical cases, diagnostic accuracy can be increased con-
siderably if complementary information is obtained from different tracers. For instance,
in coronary artery disease (CAD) assessment, evaluation of both myocardial blood flow
(MBF) and viability is usually required to provide an accurate diagnosis of the disease
[1]. In these cases, it would be technically and economically advantageous to reduce
the number of scans to the minimum. Several strategies have been proposed so far in
order to enable the possibility of performing PET scans with multiple tracers
simultaneously [2–6].
However, multi-tracer PET imaging may require obtaining the arterial input function
(AIF) corresponding to each radiotracer involved in the scan. The main problem of ex-
plicit dual AIF determination is the undistinguishable nature of the annihilation pho-
tons coming from both radiotracers. Nonetheless, a spectroscopic analysis of the
gamma emissions from blood samples containing two radiotracers could discriminate
and separate both signals if at least one of the radiotracers contains a non-pure β+
emitter [7] that produces additional gamma emissions with an energy than can be dis-
tinguished from the annihilation photons. The feasibility of this technique has been
previously demonstrated in cardiac PET studies with co-injection of 68Ga-DOTA and
18FDG for the determination of myocardial blood flow [8, 9], extracellular volume, and
myocardial viability in a single scan [10].
This technique is based on gamma spectroscopic analysis of discrete blood sam-
ples manually withdrawn from the patient while multi-tracer PET scan is in pro-
gress. However, when obtained from manual blood sampling, AIFs are discrete
and temporally limited by the rate at which the samples are obtained. Addition-
ally, this method implies an increase of radiation exposure of the operating
personnel and is more prone to errors as it requires rapid manual handling. To
address these issues on single-tracer PET scans, several automatic blood sample
detectors (hereinafter referred to as detectors) have been developed over the years
that analyze on-the-fly the blood extracted from the patient during the PET
acquisition. Existing detectors are based on the detection of either positrons
[11, 12] or annihilation photons. Most of these gamma detection devices use scintillation
crystals (such as BGO [13], GSO [14], NaI [15], or LYSO [16]) coupled to
photomultiplier tubes (PMTs). However, alternatives have also been proposed,
such as a CZT-based device [17] and LSO crystals coupled to an avalanche
photodiodes (APDs) [18], which are more compact and can operate under
magnetic fields.
The aim of this study was to develop a novel detector based on silicon photomulti-
pliers (SiPMs) for AIF measurements on single- and multi-tracer PET imaging. The
performance characteristics of the detector were evaluated and its capability for sepa-
ration of dual AIFs using gamma spectroscopic analysis was tested. In addition, the
accuracy of the detector and the capability to work under realistic experimental
conditions were tested on in vivo studies.
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Methods
Blood sample detector design
The proposed detector consists of two detection units, each one made with a 50
× 50 × 25 mm3 CsI(Tl) scintillation crystal with diffuse surfaces (Scionix Holland,
Bunnik, The Netherlands) wrapped with a white diffuse plastic reflector. On the
center of one of the 50 × 25 mm2 faces, an area of 4 × 4 mm2 is left unwrapped
for optical readout. CsI(Tl) was selected for its high detection efficiency, high
light yield, and absence of intrinsic radioactivity, which allows performing mea-
surements in single and coincidence modes making it suitable for PET and
SPECT radiotracers. Each crystal is coupled with optical grease to a SiPM (ASD-
RGB4S-P, AdvanSiD, Trento, Italy) with an active area of 4 × 4 mm2 operated at
31 V. SiPMs are compact, MR compatible, can be operated at low voltage, and
have a very high gain (106). SiPMs are connected to amplification boards based
on inverting transimpedance amplifiers (ASD-EP-EB-N - SiPM Evaluation Board,
AdvanSiD, Trento, Italy). Crystals are placed side-by-side along one of the 50 ×
50 mm2 faces with an 11.5-mm gap between them (see Fig. 1a). The crystals,
SiPMs, and readout electronics are placed within a 3D-printed enclosure (see Fig.
1b). The blood sampling catheter is placed in the center of the gap between crys-
tals in a 3D-printed U-grooved holding cassette. This piece can be fixed to the
detector enclosure, allowing for measurements in single and coincidence modes
and ensuring a good reproducibility. The detector shielding is made of a double
layer of 3-cm-thick lead bricks in order to minimize the detection of external
radiation.
Data acquisition and signal processing
The signals from both detection units are digitized (15 MS/s) with an oscilloscope
(Picoscope Series 2206A, Pico Technology Ltd, Cambridgeshire, UK) and sent to a PC
for further processing using a custom-made application based on the oscilloscope’s
C++ API. All pulses triggered by a falling edge discriminator with a threshold of −50mV
Fig. 1 External (a) and internal (b) views of the blood sample detector developed in this study. The device
consists of two 50 × 50 × 25 mm3 CsI(Tl) scintillation crystals (blue boxes) coupled on one of the 50 × 25
mm2 faces to a 4 × 4mm2 SiPM (hidden in this illustration). Crystals are placed at 11.5-mm distance. The
catheter (red tube) is placed in the gap between crystals with a holding cassette (white piece)
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are integrated for 2 μs (no filters were applied) to obtain the energy deposited by the
gamma photons and stored as single events for each detector. The signal is also recorded
for 1 μs pre-trigger, and the average of those pre-trigger samples is used for baseline cor-
rection. Time stamps are generated by the leading edge discrimination in both detectors.
Single events with a time difference below 300 ns are also stored as coincidence events.
Random coincidences are estimated based on the single rates [19]. Environmental
background events are subtracted from single and coincidence events. For that purpose, a
2-h measurement with no activity in the catheter was recorded.
Device characterization
Sensitivity, energy resolution, coincidence resolving time and count rate losses
In order to characterize the detector, an 0.8-mm internal diameter (ID) catheter (Tygon
S3 E-3603, Saint-Gobain Performance Plastics Co., Akron, OH) was filled with 18FDG
at an initial activity concentration of 900 kBq/mL and placed in the detector with the
active length centered with the detection units. A 15-h acquisition was performed con-
sisting of 150 frames of 1-min duration with 5-min gap intervals. The energy spectra
were obtained and calibrated using the 511-keV peak for every acquisition in order to
compensate for temperature-dependent gain variations. The energy resolution at the
511-keV photopeak was obtained by fitting to a Gaussian.
Sensitivity was computed as the slope of the linear fit of the events rate (singles or
coincidences) measured within an energy window of 350–700 keV against their corre-
sponding activity concentration. This fit was performed for the low count rate measure-
ments. Count rate losses were estimated for single events assuming that no events are
lost at low count rate. Coincidence resolving time (CRT) was derived from the time
difference histogram for coincidence events within the same energy window of
350–700 keV by interpolation between the two bins on each side of the maximum
that are immediately above and below the half maximum.
Minimum detectable activity
Minimum detectable activity (MDA) determines the smallest activity concentration that
can be detected with a certain confidence level [20]. MDA depends on sensitivity of the
detector (s), the duration of the measurement (T), and background events (NB) detected








where f is the branching ratio for β+ decays (0.967 for 18F). NB was measured without and
with the presence of an external source of activity. In the first case, only the environmen-
tal radiation contributes to background radiation, whereas in the second case, the
radiation emitted from the patient itself can penetrate the shielding and contribute to
background signal. Consequently, MDA was determined in both scenarios for both single
and coincidence events using an energy window of 350–700 keV. Details about the setup
employed for the background measurements with an external activity source are given in
the following section. In each case, background measurements of 2–3min were
performed in three independent acquisitions. The results are presented as mean ± SD.
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In vivo evaluation
The performance of the detector was evaluated in vivo in animals injected with 18FDG.
Three healthy female large white pigs (mean weight = 45 ± 4 kg) were anesthetized by
intramuscular injection of ketamine (20 mg/kg), xylazine (2 mg/kg), and midazolam
(0.5 mg/kg), and maintained by continuous intravenous infusion of ketamine (2 mg/kg/
h), xylazine (0.2 mg/kg/h), and midazolam (0.2 mg/kg/h). Oxygen saturation levels via
pulse oximetry, and electrocardiogram signal, were monitored throughout the study.
The coccygeal artery of the animal was cannulated, and arterial blood was withdrawn
through an 0.8-mm ID catheter at 5 mL/min using a peristaltic pump. The animals re-
ceived a bolus injection of heparin and the catheter was washed with heparinized saline
to prevent clotting. The animal was placed in a PET/CT Gemini TF-64 scanner (Philips
Healthcare, Best, The Netherlands) and the scanner table was moved to the position
were cardiac PET acquisitions are routinely performed. The detector was placed at
about 40 cm from the animal’s tail in order to minimize blood dispersion inside tubing.
18FDG (155 ± 12MBq) was prepared in 6 mL and infused at a rate of 1.0 mL/s through
a marginal ear vein, followed by a 6-mL saline flush at the same rate. The acquisition
with the detector started with the radiotracer injection and lasted for 5 min. The AIF
was obtained with the detector (AIFD) in consecutive 5-s frames using the single events
recorded in the 350–700 keV energy window and converted to activity concentration
using the sensitivity previously obtained. Decay correction was applied. Afterwards,
measurements for MDA determination with an external source of activity were
performed by placing an empty catheter in the device and leaving everything else in the
same position.
In order to validate AIFD results, blood samples were collected into sample tubes
after passing through the detector following this temporal scheme: 20 × 5 s, 8 × 10 s, 6
× 20 s. Then, the tubes were briefly centrifuged to provide a reproducible geometrical
distribution of the blood and later analyzed using a well counter (Wallac 1470 Perkin
Elmer, Waltham, Massachusetts, USA) applying dead time and decay corrections. The
well counter was previously calibrated to convert measurements to activity values. The
volume for each blood sample was determined as the weight difference between empty
and filled tubes and applying a blood density of 1.03 g/mL [21]. Finally, the activity con-
centration of 18FDG was calculated for each blood sample obtaining the AIF derived
from the well counter (AIFWC). The time delay existing between AIFD and AIFWC was
corrected by maximizing the cross-correlation between both curves, which had been
previously interpolated every 5 s.
Multi-tracer AIF detection by spectroscopic analysis
Pure β+ isotopes such as 18F only emit positrons that result in 511-keV annihilation
photons, while non-pure β+ isotopes like 68Ga emit additional non-annihilation pho-
tons, although only those with 1.077MeV are emitted in a significant fraction of the de-
cays (3.22%) [22]. Thus, the ratio of events recorded at high-energy (> 750 keV) and
low-energy windows (350–700 keV) (see Fig. 2) can be used to determine the amount
of 18F and 68Ga in a sample containing any combination of both isotopes.
Two acquisitions were made in order to obtain the calibration data required to im-
plement the proposed method. An 0.8-mm ID catheter was filled with 68Ga or 18F
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respectively with an initial activity concentration of 1200 kBq/mL (measured with an
activimeter). Afterwards, the catheter was placed in the device and data was recorded
for several hours acquiring frames of 1 min with 5-min gap intervals. Each frame was
processed to obtain the total single rate at high-energy window (750–2000 keV, SHE)
and the coincidences rate at low-energy window (350–700 keV, CLE). The ratio between
SHE and CLE could be used, in theory, to calibrate the measurements for each isotope.
However, we observed that, at higher count rates, the increase of SHE is not linear with
CLE due to pile-up events. Therefore, in order to include this effect, SHE must be
calibrated as a function of CLE. For that purpose, the variation of SHE against CLE was
represented and fitted to a third-degree polynomial for each isotope (SHE,F(CLE) and
SHE,G(CLE) for pure
18F and 68Ga respectively). When measuring SHE and CLE for a
sample containing an unknown mixture of 18F and 68Ga (SHE,Mix), the relative activity
of each isotope (aGa,D and aF,D where aF,D + aGa,D = 1) can be obtained using the
following expression:
SHE;Mix CLEð Þ ¼ aGa;D  SHE;G CLEð Þ þ 1−aGa;D
  SHE;F CLEð Þ ð2Þ
assuming that the contribution of pile-up events is equally distributed between both
isotopes.
The ability of the developed detector to obtain separated AIFs of tracers labeled with
different isotopes (68Ga and 18F) was tested in vitro. To do so, a catheter filled with a
mixture of 73% 68Ga and 27% 18F with an initial total activity concentration of 1200
kBq/mL was placed in the detector. The activity was measured separately for each iso-
tope with an activimeter and the mixture was prepared afterwards. Data was recorded
for several hours acquiring frames of 1 min with 5-min gap intervals. The relative activ-
ity of both isotopes was constantly changing over time due to their different half-lives
(109 min for 18F and 68 min for 68Ga).
The initial activity concentration (c(ti) = 1200 kBq/mL) was much higher than the
typical values that can be measured in an AIF of an in vivo experiment on large ani-
mals. In the later studies, the activity concentration usually ranges between 10 and 200
kBq/mL, and the duration of the time frames of the dynamic PET acquisition is
Fig. 2 Normalized energy spectra of single events recorded from 18F (pure β+ emitter, red) and the 68Ga
(non-pure β+ emitter, blue) shown in linear (a) and logarithmic (b) scales. The green and orange boxes
represent the energy windows set at (350, 700) and (750, 2000) keV to distinguish between photopeak (low
energy) and high-energy events. The events recorded in the high-energy window are relatively higher for
68Ga than for 18F compared with the event recorded in the photopeak
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frequently set from 5 s (in those frames where the activity concentration is high and
changes rapidly) up to 60–180 s (for those frames where the activity concentration is
low and the changes over time are less significative). Hence, in order to evaluate our
experiment in more realistic conditions, our 1-min acquisitions were trimmed
depending on the activity concentration of each acquisition as follows:
t ¼ 60 s ; when max c tð Þð Þ ≤ 10 kBq=mL
t ¼ 10 s ; when 10 kBq=mL < max c tð Þð Þ≤50 kBq=mL




SHE,Mix and CLE were obtained for each frame and aGa,D was calculated using Eq. (2).
These results were compared against theoretical values (aGa,A) obtained from their
initial activity and taking into account their half-lives. The mean relative difference
between aGa,D and aGa,A was obtained and reported as percentage.
Results
Detector performance and in vivo evaluation
The energy resolution and the CRT of the device was determined using one of the
acquisitions performed at low count rate, obtaining 35% FWHM at 511 keV (see
Fig. 2) and 131 ns FHWM (see Fig. 3) respectively. The count rate losses for single
events are shown in Fig. 4. Figure 4a displays the recorded single rate as a function
of the activity concentration within the catheter and Fig. 4b illustrates the
deviation of measured single rate from the expected value as a function of the
activity concentration. Importantly, for activity concentrations within the range of
standard in vivo experiments (10–200 kBq/mL), the count rate losses are lower
than 2%. Random coincidences were also computed and can be considered negli-
gible (< 0.3%). The sensitivities obtained for single and coincidence events were
22.6 cps/(kBq/mL) and 1.7 cps/(kBq/mL) respectively.
Fig. 3 Time difference histogram obtained with the detector using 18F for a 1-min acquisition with an
energy window of 350–700 keV leading to a CRT of 131 ns FWHM
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The MDA was computed for single and coincidence events with and without an ex-
ternal activity source. In the absence of an external source, the MDA was 0.05 ± 0.02
(singles) and 0.10 ± 0.03 kBq/mL (coincidences), while the results with an external
source were 0.30 ± 0.08 kBq/mL (singles) and 0.25 ± 0.05 kBq/mL (coincidences).
Figure 5 shows the AIFs obtained with our detector (AIFD) from three in vivo studies
in which blood was withdrawn at a rate of 5 mL/min from an 0.8-mm ID catheter. An
excellent correlation between AIFD and the blood samples analyzed with the well
counter (AIFWC) was found (r = 0.996, p < 0.0001).
Multi-tracer AIF separation by spectroscopic analysis
Figure 6 shows the calibration curves performed for the in vitro measurements of pure
18F and pure 68Ga (SHE,F and SHE,Ga respectively) as well as the high energy single rate cor-
responding to an unknown mixture of these radioisotopes (SHE,Mix). It can be observed
that the SHE,Mix dataset gets closer to the pure
18F measurements for lower CLE since
18F
activity decreases slower than 68Ga and consequently the relative activity of 18F increases
over time. All datasets tend to SHE = 0 at low activity concentrations, which confirms that
the background subtraction to every acquisition has been correctly performed.
The relative activity of 68Ga in the mixture was calculated using Eq. (2) and the
comparison against the theoretical values showed a very strong correlation (r = 0.97,
p < 0.0001, Fig. 7). The mean relative difference between aGa,D and aGa,A was δ = (3 ± 10)%.
When the acquisition was trimmed as described in Eq. (3) to analyze more realistic activity
concentrations and time frame duration, the correlation was still very good (r = 0.91,
p < 0.0001), with only a slight increase in the variation of the mean deviation from
the true values (δ = (2 ± 13)%).
Discussion
Our results show that the detector presented in this study has a high sensitivity and it can
obtain accurate and stable measurements of AIFs under realistic conditions. The device can
work within a wide range of activity concentrations (up to 400 kBq/mL with dead time
losses below 2%, Fig. 4) and exhibits a very low MDA for both single and coincidence events
(0.25 and 0.30 kBq/mL respectively) in the presence of an external activity source.
Fig. 4 a Single rate (SR) detected by the detector as a function of activity concentration (c, red dots) inside
the catheter. A linear fit of the measured SR at low c when count rate losses are negligible is also shown
(blue dashed line). b Count rate losses (δSR) as a function of activity concentration
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Therefore, the detection limit of this device is sufficiently low to measure typical input
functions observed in human or clinical cases, which typically range from 5 to 200 kBq/mL.
Furthermore, the device is potentially MR compatible thanks to the SiPM-based detection
system, although further work (such as mechanical and electronic components) would be
required to enable this option.
Fig. 5 AIFs obtained with the detector (AIFD, red curves) compared with the AIFs obtained from collected
blood sampling analyzed in a well counter (AIFWC, black curves) on three pigs that were injected with
18FDG. Pearson’s correlation obtained in all cases is excellent (mean r = 0.996, p < 0.0001).
Fig. 6 Single rates within the high-energy window (SHE) as a function of the coincidence rate within the
low-energy window (CLE) for measurements performed with pure
18F (red dots), pure 68Ga (blue dots), and
a mixture of both radioisotopes (black dots). The results for the pure samples were fitted to a third-degree
polynomial (blue and red lines for pure 68Ga and 18F respectively). These fits are used as the calibration
curves named as SHE,F and SHE,Ga in Eq. (2). Green squares represent the expected values for the mixture
obtained using Eq. (2) and the theoretical relative activity (aGa,A)
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The in vivo performance of the detector has been evaluated with three pigs leading
to an excellent correlation between the AIFs obtained with the device and those
obtained from the analysis of collected blood samples in a well counter (mean correlation
r = 0.996, all with p < 0.0001).
The configuration parameters used in these studies, such as activity concentra-
tions, tubing size, and time frame scheme are similar to those used in human stud-
ies. Therefore, this device would be suitable for application in human studies. In
case of studies with rats, the inner diameter of the tubing usually ranges from 0.18
to 0.64 mm, which translates in a reduction of 60 to 95% of the active volume.
However, the injected dose per gram for rats is about 30 times higher than for
humans. Thus, our device could also be used in rat studies since similar count rate
to that obtained in pig studies is expected. Moreover, the blood withdrawal rate
could be reduced proportionally to the catheter volume reduction [18] while
keeping a similar blood renewal rate in the active length of de device. For example,
for a 0.18-mm ID tubing, blood could be withdrawn at a rate of 0.25 mL/min with
similar accuracy to the results presented in this work.
When measuring AIF with a blood sampling detector, blood activity dispersion inside
the tubing reveals as a critical factor that may introduce large errors in the final quanti-
fication. Many approaches have been proposed to correct for dispersion [23–25] ana-
lytically, but it is still advisable to minimize the main sources of dispersion in the
experimental setup, such as tubing length or blood withdrawal rate. In this aspect, the
compact design of our detector as a consequence of the use of SiPM detectors makes
possible to place it in close proximity to the subject, which turns into a reduced blood
dispersion effect. Furthermore, the capability of the detector to record coincidence
events reduces the background events from external sources.
Fig. 7 Comparison between the relative activity of 68Ga obtained with the detector using the gamma
spectroscopy analysis of a mixture of 68Ga and 18F (aGa,D) and the theoretical relative activity (aGa,A). The
data collected from the 1-min acquisitions were analyzed entirely (gray squares) and partially (following
scheme given in Eq. (3), black dots). Pearson’s r correlation of the datasets with the true values (aGa,A) are r
= 0.97 and r = 0.91 respectively. Dashed blue line represents the identity line
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To our knowledge, available blood sample detectors can only measure single-tracer
AIFs. In contrast, the detector presented in this work not only provides the live photon
count rate emitted from the blood but also stores and analyses the gamma energy
spectrum of each event recorded during the acquisition (both in single and coincidence
modes). This feature allows obtaining individual tracer AIFs on multi-tracer PET
studies by using the blood spectroscopic analysis described in [10].
The gamma spectroscopic analysis technique has been successfully implemented and
validated in our detector for its application in multi-tracer PET studies when one of
the radiotracers is based on a non-pure β+ emitter. The analysis for multi-tracer AIF
detection was tested using the detector with mixtures of a pure β+ emitter (18F) and a
non-pure β+ emitter (68Ga). The detection of additional gamma photons emitted by
68Ga (see Fig. 4) enabled to disentangle the activity of each radioisotope. The energy
resolution (35% FWHM at 511 keV) and CRT (131 ns FHWM) obtained for our
detector are poor compared with other detectors [16–18]. These results are due to the
large difference between the size of the SiPMs (4 × 4mm2) and the size of the scintilla-
tion crystal (50 × 50 × 25mm3). Although the energy resolution is not a critical factor
for standard blood sampling analysis, it may limit the accuracy for blood sampling
spectroscopy. However, validation results shown in Fig. 7 demonstrate the capability of
the developed device to separate the contribution of 18F and 68Ga for a sample contain-
ing a mixture of both isotopes with a very good correlation (r = 0.91, p < 0.0001).
Nevertheless, the CRT did not affect the device performance as the obtained fraction of
random events was very low in all cases.
Conclusions
We have developed a blood sample detector based on SiPM technology capable of
recording simultaneously single and coincidence events with different energy windows.
The performance parameters of this detector have been obtained leading to excellent
results in terms of sensitivity and MDA compared with other devices presented in the
literature [17]. The detector was tested in vivo in pigs injected with a single radiotracer
and the results were validated showing excellent results. Therefore, the device pre-
sented in this study allows performing fully automatic single- and multiple-tracer PET
studies. Moreover, this is the first blood sample detector based on SiPM technology
which offers many advantages in terms of cost, compactness, performance, and MR
compatibility.
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